Research Topic · Peer-Reviewed

Covid-19 Serological Testing

Serological testing for Covid-19 is a crucial component of the global effort to control the spread of this highly infectious virus. Covid-19 is caused by the SARS-CoV-2 virus, which is primarily transmitted through respiratory droplets from infected individuals. Serological testing is used to identify the presence o…

Curated from this journal's research 📚 2 peer-reviewed articles cited Cited 6× across the literature 🔖 ISSN 2692-1537 🗓 Reviewed July 2026

Overview

Serological testing for Covid-19 is a crucial component of the global effort to control the spread of this highly infectious virus. Covid-19 is caused by the SARS-CoV-2 virus, which is primarily transmitted through respiratory droplets from infected individuals. Serological testing is used to identify the presence of antibodies in the blood, which are produced by the immune system to neutralize the virus. There are two types of antibodies that are produced by the immune system in response to an infection - IgM and IgG. IgM antibodies are produced in the initial phase of the infection and indicate a recent or current infection, while IgG antibodies are produced later and provide long-term immunity against the virus. Serological testing for Covid-19 therefore helps to identify individuals who have been infected, as well as those who have developed immunity against the virus. Serological testing is particularly important for individuals who may have been exposed to the virus but did not exhibit any symptoms. This is because such individuals may have developed an immune response without realizing they were infected. Serological testing can also help to identify individuals who are at high risk of developing severe Covid-19 symptoms due to underlying health conditions, such as diabetes or hypertension. Overall, serological testing is a critical tool for the ongoing fight against Covid-19. It enables healthcare providers to identify and track the spread of the virus, as well as monitor the effectiveness of vaccination programs. With the continued increase in global Covid-19 cases, serological testing will remain a valuable resource in our collective efforts to mitigate the impact of this devastating pandemic.

Research published in this journal

2 peer-reviewed articles, ranked by relevance. Each links to its DOI.

2020

The Novel Coronavirus 2019 (COVID-19): A Narrative Review

Rezapour BarataliCorresponding author
Department of Public Health, Faculty of Health, Assistant Professor, PhD in Health education and promotion, Urmia University of Medical Sciences, Urmia, Iran
International Journal of Coronaviruses Cited by 2 doi:10.14302/issn.2692-1537.ijcv-20-3373

How this research is being cited

The 2 articles above have been cited 6 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Covid-19 Serological Testing, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in International Journal of Coronaviruses (ISSN 2692-1537).

Journal editorial board
Dr. Omeed Memar · USA Dr. SUDIPTI GUPTA · United States Dr. Jose Luis Turabian · Spain

This page summarises published research for orientation; it is not medical or professional advice.